Evaluation of cerebrovascular processes and their reactions to pharmacotherapy by means of ultrasonic methods.
Calculation of diameter, wall movement, systolic and diastolic flow velocity in the vertebral and carotid artery by means of ultrasonic A-mode-echography and DOPPLER sonography permits identification and quantitative evaluation of cerebrovascular processes in extracranial and intracranial branches and their response to stress, especially in general and regionally accentuated arteriosclerosis, e.g. in predominant vertebrobasilar insufficiency. Their principal reagibility to pharmacotherapy under certain extracerebrovascular preconditions ins demonstrated by significant increase of the reduced hemodynamic parameters accompanied with significant elevation of decreased orthostatic BP after treatment with Raubasine, Dihydroergotamine and Dihydroergocristine.
D000368:Aged; D002545:Brain Ischemia / Q000188:drug therapy*; D002340:Carotid Artery Diseases / Q000188:drug therapy; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004087:Dihydroergotamine / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012212:Rheology; D046948:Secologanin Tryptamine Alkaloids; D014715:Vertebrobasilar Insufficiency / Q000188:drug therapy; D015016:Yohimbine / Q000627:therapeutic use
D046948:Secologanin Tryptamine Alkaloids; D004088:Dihydroergotoxine; D015016:Yohimbine; D004087:Dihydroergotamine; C005709:raubasine